INSPECS Group Stock
INSPECS Group plc
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United Kingdom
- CEO
- Richard David Peck
- Employees
- 1,656
- Market cap
- £98 M
- IPO
- 27/02/2020
INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufacturing; and Lenses segments. The company offers its products under the…
INSPECS Group stock: price history
1D
+0.0%
1W
+0.0%
1M
-6.2%
6M
+7.8%
YTD
+25.9%
1Y
+100.0%
2Y
+59.3%
5Y
-75.7%
10Y
–
Next earnings date
Next earnings date
11/06/2027 (in 237 days)
Volatility around earnings
~5% weaker price swings than usual
Ask the agents about INSPECS Group
INSPECS Group stock metrics
P/E
-38.3
P/B
1.05
EV/EBITDA
6.66
RETURN ON EQUITY
-0.6%
NET MARGIN
-0.5%
DEBT/EQUITY
0.63
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
56.7%
FLOAT SHARES
61,885,580
AVG. DAILY VOLUME (30D)
6,246
Dividends
Comparable stocks
Frequently asked questions about INSPECS Group stock
What does INSPECS Group do?
INSPECS Group plc is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United Kingdom.
The CEO is Richard David Peck, the company employs around 1,656 people.
The IPO was on 27/02/2020; the stock trades on LSE under the ticker SPEC.L.
When does INSPECS Group report next?
The next earnings date is 11/06/2027.
Around past earnings, price swings were roughly -5% stronger than usual.
Does INSPECS Group pay a dividend?
Yes. The last dividend was £1.25 per share, ex-date 01/09/2022, paid on 06/10/2022.
The dividend yield is 0.0% (as of 30/06/2026).
Which stocks are comparable to INSPECS Group?
Comparable stocks include ConvaTec Group, Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Sartorius, Solventum and Baxter International.
How can I get INSPECS Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess INSPECS Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.